Conference Coverage

VIDEO: Could a deep Koebner phenomenon trigger psoriatic arthritis?


 

AT THE EULAR 2015 CONGRESS

References

ROME – Psoriasis patients with a past history of bone or joint trauma had about 50% higher risk of later developing psoriatic arthritis than did those without a history of trauma in a longitudinal, population-based study of more than 70,000 psoriasis patients in the United Kingdom.

The relationship between trauma and later development of psoriatic arthritis could involve a deep Koebner phenomenon similar to what is observed with the Koebner phenomenon in the skin, suggested lead investigator Dr. Thorvardur Löve in an interview at the European Congress of Rheumatology.

Based on these findings, “one of the things that we are very excited about is the potential to think of strategies and test strategies that might be used in psoriasis patients once they are injured. So should we do anything different in an injured psoriasis patient, for instance, some sort of preventive treatment?” said Dr. Löve of Landspitali University Hospital in Reykjavik, Iceland.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

jevans@frontlinemedcom.com

Recommended Reading

BSR: Multiple benefits seen with intensive psoriatic arthritis therapy
MDedge Internal Medicine
Psoriasis, PsA increase temporomandibular disorder risk
MDedge Internal Medicine
Anti-TNFs help psoriatic arthritis patients get back to work
MDedge Internal Medicine
WCD: Tofacitinib’s benefits for psoriasis persist for 2 years
MDedge Internal Medicine
VIDEO: EULAR updates cardiovascular-disease risk recommendations
MDedge Internal Medicine
VIDEO: Predicting anti-TNF failure in psoriatic arthritis
MDedge Internal Medicine
EULAR: Epigenetics points to anti-TNF efficacy in psoriatic arthritis
MDedge Internal Medicine
WCD: Psoriasis plus depression magnifies MI risk
MDedge Internal Medicine
Large-scale psoriasis study links trauma to arthritis
MDedge Internal Medicine
Amgen’s termination of brodalumab stuns psoriasis world
MDedge Internal Medicine